中源協和(600645.SH)下屬簽訂採購協議 擬採購40台Ultra60全自動免疫組化染色機
格隆匯2月18日丨中源協和(600645.SH)公佈,經協商,公司下屬子公司中杉金橋與美聯泰科簽訂採購協議,中杉金橋擬向美聯泰科採購Ultra60全自動免疫組化染色機,採購數量為40台,每台41萬元,採購總金額為1640萬元,採購週期為2020年2月29日到2020年12月31日。交易雙方協議尚未簽署。
本次採購事項屬於子公司正常的生產經營活動,Ultra60型全自動免疫組化染色機為美聯泰科註冊生產(一類備案註冊,證書編號【京經械備20190133號】),此款設備為中杉金橋定製研發產品,中杉金橋享有獨家採購權益。本次交易價格既無獨立第三方的市場價格,也無獨立的非關聯交易價格可供參考,以合理成本費用加合理利潤確定,每台設備生產成本約為29.9萬元,增值税和附加税費約為5.3萬元,確定每台設備交易價格為41萬元。
公司下屬子公司中杉金橋主營免疫組化,致力服務於中國病理市場,由於病理診斷試劑的銷售與免疫組化設備密切相關,免疫組化檢測已經逐步實現儀器化、自動化,美聯泰科擁有自己註冊生產的Ultra60型全自動免疫組化染色機(一類備案註冊,證書編號【京經械備20190133號】),設備性能和價格均有優勢,為穩固和提升中杉金橋病理診斷試劑市場份額,中杉金橋決定向美聯泰科採購Ultra60型全自動免疫組化染色機,用以提高試劑的銷售及與終端用户形成緊密的應用關係,繼續保持行業內較高的市場佔有率,提高公司的競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.